First Description of KPC-2-Producing Klebsiella oxytoca Isolated from a Pediatric Patient with Nosocomial Pneumonia in Venezuela

During the last decade, carbapenem resistance has emerged among clinical isolates of the Enterobacteriaceae family. This has been increasingly attributed to the production of β-lactamases capable of hydrolyzing carbapenems. Among these enzymes, Klebsiella pneumoniae carbapenemases (KPCs) are the mos...

Full description

Saved in:
Bibliographic Details
Main Authors: Indira Labrador, María Araque
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Case Reports in Infectious Diseases
Online Access:http://dx.doi.org/10.1155/2014/434987
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548138190110720
author Indira Labrador
María Araque
author_facet Indira Labrador
María Araque
author_sort Indira Labrador
collection DOAJ
description During the last decade, carbapenem resistance has emerged among clinical isolates of the Enterobacteriaceae family. This has been increasingly attributed to the production of β-lactamases capable of hydrolyzing carbapenems. Among these enzymes, Klebsiella pneumoniae carbapenemases (KPCs) are the most frequently and clinically significant class-A carbapenemases. In this report, we describe the first nosocomial KPC-2-producing K. oxytoca isolated from a pediatric patient with pneumonia admitted to the intensive care unit at The Andes University Hospital, Mérida, Venezuela. This strain was resistant to several antibiotics including imipenem, ertapenem, and meropenem but remained susceptible to ciprofloxacin, colistin, and tigecycline. Conjugation assays demonstrated the transferability of all resistance determinants, except aminoglycosides. The isolate LMM-SA26 carried a ~21 kb conjugative plasmid that harbored the blaKPC-2, blaCTX-M-8, and blaTEM-15 genes. Although carbapenem resistance in the Enterobacteriaceae is still unusual in Venezuela, KPCs have a great potential to spread due to their localization on mobile genetic elements. Therefore, rapid detection of KPC-carrying bacteria with phenotypic and confirmatory molecular tests is essential to establish therapeutic options and effective control measures.
format Article
id doaj-art-a297918e29e04a06aa72bb1ece488bfc
institution Kabale University
issn 2090-6625
2090-6633
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Case Reports in Infectious Diseases
spelling doaj-art-a297918e29e04a06aa72bb1ece488bfc2025-02-03T06:42:05ZengWileyCase Reports in Infectious Diseases2090-66252090-66332014-01-01201410.1155/2014/434987434987First Description of KPC-2-Producing Klebsiella oxytoca Isolated from a Pediatric Patient with Nosocomial Pneumonia in VenezuelaIndira Labrador0María Araque1Laboratorio de Microbiología Molecular, Departamento de Microbiología y Parasitología, Facultad de Farmacia y Bioanálisis, Universidad de Los Andes, Mérida 5101, VenezuelaLaboratorio de Microbiología Molecular, Departamento de Microbiología y Parasitología, Facultad de Farmacia y Bioanálisis, Universidad de Los Andes, Mérida 5101, VenezuelaDuring the last decade, carbapenem resistance has emerged among clinical isolates of the Enterobacteriaceae family. This has been increasingly attributed to the production of β-lactamases capable of hydrolyzing carbapenems. Among these enzymes, Klebsiella pneumoniae carbapenemases (KPCs) are the most frequently and clinically significant class-A carbapenemases. In this report, we describe the first nosocomial KPC-2-producing K. oxytoca isolated from a pediatric patient with pneumonia admitted to the intensive care unit at The Andes University Hospital, Mérida, Venezuela. This strain was resistant to several antibiotics including imipenem, ertapenem, and meropenem but remained susceptible to ciprofloxacin, colistin, and tigecycline. Conjugation assays demonstrated the transferability of all resistance determinants, except aminoglycosides. The isolate LMM-SA26 carried a ~21 kb conjugative plasmid that harbored the blaKPC-2, blaCTX-M-8, and blaTEM-15 genes. Although carbapenem resistance in the Enterobacteriaceae is still unusual in Venezuela, KPCs have a great potential to spread due to their localization on mobile genetic elements. Therefore, rapid detection of KPC-carrying bacteria with phenotypic and confirmatory molecular tests is essential to establish therapeutic options and effective control measures.http://dx.doi.org/10.1155/2014/434987
spellingShingle Indira Labrador
María Araque
First Description of KPC-2-Producing Klebsiella oxytoca Isolated from a Pediatric Patient with Nosocomial Pneumonia in Venezuela
Case Reports in Infectious Diseases
title First Description of KPC-2-Producing Klebsiella oxytoca Isolated from a Pediatric Patient with Nosocomial Pneumonia in Venezuela
title_full First Description of KPC-2-Producing Klebsiella oxytoca Isolated from a Pediatric Patient with Nosocomial Pneumonia in Venezuela
title_fullStr First Description of KPC-2-Producing Klebsiella oxytoca Isolated from a Pediatric Patient with Nosocomial Pneumonia in Venezuela
title_full_unstemmed First Description of KPC-2-Producing Klebsiella oxytoca Isolated from a Pediatric Patient with Nosocomial Pneumonia in Venezuela
title_short First Description of KPC-2-Producing Klebsiella oxytoca Isolated from a Pediatric Patient with Nosocomial Pneumonia in Venezuela
title_sort first description of kpc 2 producing klebsiella oxytoca isolated from a pediatric patient with nosocomial pneumonia in venezuela
url http://dx.doi.org/10.1155/2014/434987
work_keys_str_mv AT indiralabrador firstdescriptionofkpc2producingklebsiellaoxytocaisolatedfromapediatricpatientwithnosocomialpneumoniainvenezuela
AT mariaaraque firstdescriptionofkpc2producingklebsiellaoxytocaisolatedfromapediatricpatientwithnosocomialpneumoniainvenezuela